Steady-state pharmacokinetics of etravirine and lopinavir/ritonavir melt extrusion formulation, alone and in combination, in healthy HIV-negative volunteers.
about
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.Physiologically Based Pharmacokinetic Modeling for Predicting the Effect of Intrinsic and Extrinsic Factors on Darunavir or Lopinavir Exposure Coadministered With Ritonavir.The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.
P2860
Steady-state pharmacokinetics of etravirine and lopinavir/ritonavir melt extrusion formulation, alone and in combination, in healthy HIV-negative volunteers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@en
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@nl
type
label
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@en
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@nl
prefLabel
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@en
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@nl
P2093
P2860
P356
P1476
Steady-state pharmacokinetics ...... althy HIV-negative volunteers.
@en
P2093
Goedele De Smedt
James Witek
Kurt Spittaels
Monika Schöller-Gyüre
Richard M W Hoetelmans
Sophie H Akuma
Thomas N Kakuda
Veerle Vyncke
P2860
P304
P356
10.1177/0091270012445205
P577
2013-01-24T00:00:00Z